Login to Your Account

Genentech Earnings: Lucentis Strong, Oncology Weakening

By Trista Morrison

Thursday, October 12, 2006
Genentech Inc. beat expectations for the third quarter and posted strong sales of Lucentis, but weaker-than-expected performance from its oncology franchise cast a shadow over the numbers. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription